A new approach to Alzheimer’s, developed in Temecula, now backed by successful clinical trial results

0
384
Doctor with stethoscope
Valley News - Health
TEMECULA – ProdromeNeuroTM plasmalogen supplement successfully improved cognition and mobility in a recent Alzheimer’s disease clinical trial, proving Dr. Dayan Goodenowe’s 15-year theory outlined in his new book Breaking Alzheimer’s where he explains his scientific journey to expose the cause and deliver the cure. Prodrome Sciences launched the world’s first high-dose plasmalogen supplement, ProdromeNeuro, last year. A clinical trial was initiated shortly thereafter. The clinical trial results were released at the Alzheimer’s Association International Conference on July 26, 2021. ProdromeNeuro supplement successfully improved cognition and mobility in persons diagnosed with mild to moderate cognitive impairment. Conducted by Dr. Sheldon Jordan, a board-certified neurologist
Subscribe or log in to read the rest of this content.